Compare Acadia Healthcare Company Inc (ACHC) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acadia Healthcare Company Inc vs Philip Morris International Inc. — how do they compare? Acadia Healthcare Company Inc trades at $31.52 (market cap $2.96B), while Philip Morris International Inc. trades at $185.6 (market cap $289.90B). The key difference: Philip Morris International Inc. is far larger — about 97.9× Acadia Healthcare Company Inc's market cap, and Philip Morris International Inc. pays a 3.16% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | PM | |
|---|---|---|
Market Cap | $2.96B | $289.90B |
Sector | Health | Consumer Staples |
52-Week High | $35.61 | $200.17 |
52-Week Low | $11.68 | $144.33 |
Enterprise Value | $5.35B | $333.02B |
Dividend Yield | — | 3.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.53, up 2.64% today, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth with Q2 2026 earnings beating estimates, but faces profitability challenges with negative net income margins. Analyst consensus remains positive with 68% buy ratings and a $36 price target, though ongoing legal investigations create headwinds.
The outlook balances operational strength against financial risks. Revenue growth and facility expansion support upside potential, but negative profitability and legal uncertainties warrant caution. The stock offers 14% upside to consensus target if execution improves, but investors should monitor earnings sustainability and legal developments closely.
Philip Morris International (PM) trades at $189.57, up 0.81% today, with a bullish technical outlook and strong fundamentals. Recent earnings beats in Q1 and Q2 2026, alongside a 27.91% net margin in 2025, highlight profitability. However, the company faces headwinds from a $500 million impairment charge and reduced 2026 guidance due to cost pressures, as reported by Reuters on June 2, 2026.
The stock offers a dividend yield supported by cash flow, but risks include regulatory challenges and currency volatility. Analysts maintain a buy consensus with a $211.17 target, suggesting 11% upside, though investors should weigh near-term earnings pressure against long-term brand strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
